fbpx Skip to main content
 

Search

Janssen Search

Search results

652 SEARCH RESULTS FOR

research-development

Not finding what you're looking for? Visit Janssen in your country.
PAGE 8 OF 66

Pages

YUSRI A. ELSAYED, M.D., M.H.Sc., Ph.D. SENIOR VICE PRESIDENT GLOBAL ONCOLOGY THERAPEUTIC AREA HEAD As Global Oncology Therapeutic Area Head for Johnson & Johnson, Yusri Elsayed, M.D., M.H.SC, Ph.D. is responsible for the discovery, development and ...

Global CEO Initiative on Alzheimer's Disease As part of a worldwide effort to find better ways to treat the disease, Janssen joined the Global CEO Initiative on Alzheimer’s Disease (CEOi), a collaboration of public and private partnerships with ...

As the Strategy and Operations Support Leader for the Disease Interception Accelerator (DIA), Dave Yazujian drives the development and execution of the DIA strategy, ensuring operational efficiency and effectiveness and integrating input from Janssen ...

Article Type:  Human Microbiome Institute Our Work We work with our partners to translate exciting ideas into therapies and other health solutions, and to create knowledge and resources that will advance the field as a whole. Our current collaborations ...

We invite you to partner with us. We recognize the importance of building strong working partnerships that can advance the quality of healthcare globally, respect and protect the environment, and support our sense of responsibility to local communities. ...

DAVID M. LEE, M.D., Ph.D. GLOBAL THERAPEUTIC AREA HEAD IMMUNOLOGY David M. Lee, M.D., Ph.D., is Global Immunology Therapeutic Area Head for the Janssen Pharmaceutical Companies of Johnson & Johnson where he leads a team focused on end-to-end pipeline ...

Martine Lewi, MBA, Ph.D. SCIENTIFIC DIRECTOR, JCI Tine Lewi is the Scientific Director for Janssen Clinical Innovation based in Belgium. Tine is responsible for leading patient data for research initiatives and introducing novel projects in the area of ...

Empowering Black Americans for Greater Clinical Trial Representation   In honor of Black History Month, Janssen is spotlighting its commitment to increase diversity among its clinical trial participants, and to expand community engagement to build ...

JOHN C. REED, M.D., PH.D. EXECUTIVE VICE PRESIDENT PHARMACEUTICALS, R&D JOHNSON & JOHNSON As Executive Vice President, Pharmaceuticals, R&D and Johnson & Johnson (J&J) Executive Committee member, John’s mission is to focus the best ...

With the American Society of Clinical Oncology (ASCO) moving to a virtual platform for its 2020 Annual Meeting, Janssen Oncology remains determined in our efforts to champion science for patients. Thank you for visiting to check out our news from ASCO2020 ...

652 SEARCH RESULTS FOR

research-development

Not finding what you're looking for? Visit Janssen in your country.
PAGE 8 OF 66

Pages